Performance assessment of LED using human miRNAs, miR-21 (22 bases), miR-200c (23 bases), miR-16 (22 bases) and miR-205 (22 bases) and a viral miRNA miR-K12-1 (23 bases). (A) Comparison of LED (top panel) to analogous method that uses 32P-labeling (bottom panel). LED northern blots yield notably strong signals for three miRNAs expressed at varying levels in MCF7 breast cancer cell line. An exposure time as short as 30 s is sufficient for LED to generally detect miRNAs. The mature miRNA, miR-205, that is not expressed in MCF7 is used as a negative control. For both methods, phosphor image screens were used to detect the signals to eliminate any biases from imaging. (B) Evaluation of specificity of LED using K12-1 viral miRNA that is absent in MCF-7, and using three different mutants of K12-1. Data suggests single-nucleotide specificity for LED. (C) Quantification of the absolute sensitivity of LED using serially diluted K12-1 miRNA (top panel) and its comparison to the method using 32P-labeling (bottom panel). The following amounts of K12-1 RNA are spiked into 5 µg of total RNA from MCF-7 in each lane (left to right): 0, 0.00019, 0.00038, 0.00075, 0.00188, 0.00375, 0.0075, 0.015 and 0.03 µg.